A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

Name: A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls
Published: 2009
License: Public Domain

Janssen-Cilag G.m.b.H · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

dopamine schizophrenia

schizophrenia, d2-receptor occupancy, antipsychotic drugs, paliperidone er, oral risperidone, dopamine, fallypride, plasma concentration, therapeutic window, healthy controls, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

Related documents